European Journal of Clinical Microbiology

, Volume 4, Issue 2, pp 228–229 | Cite as

Treatment ofPseudomonas aeruginosa septicemia in neutropenic patients with ceftazidime

  • B. E. de Pauw
  • T. de Witte
  • J. T. P. Janssen
  • C. Haanen
Correspondence

Keywords

Internal Medicine Ceftazidime Neutropenic Patient 

References

  1. 1.
    Bauernfeind, A.: An evaluation of the activity of cephalosporins againstPseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 1981, 8, Supplement B: 111–115.Google Scholar
  2. 2.
    Singer, C., Kaplan, M. H., Armstrong, D.: Bacteremia and fungemia complicating neoplastic disease. American Journal of Medicine 1977, 62: 731–742.CrossRefPubMedGoogle Scholar
  3. 3.
    De Pauw, B. E., Kauw, F., Muytjens, H., Williams, K. J., Bothof, T.: Randomized study of ceftazidime versus gentamicin plus cefotaxime for infections in severe granulocytopenic patients. Journal of Antimicrobial Chemotherapy 1983, 12, Supplement A: 93–99.Google Scholar
  4. 4.
    Whitecar, J. P., Bodey, G. P., Luna, M.:Pseudomonas bacteremia in cancer patients. American Journal of Medical Science 1970, 260: 216–223.Google Scholar
  5. 5.
    Bodey, G. P.: Aminoglycoside use in the compromised host. In: Whelton, A., Neu, H. C. (ed.): The aminoglycosides. Marcel Dekker, New York, 1982, p. 557–583.Google Scholar
  6. 6.
    Van Dalen, R., Muytjens, H. L., Gimbrère, J. S. F.: Ceftazidime in intensive care patients. Journal of Antimicrobial Chemotherapy 1983, 12, Supplement A: 189–197.Google Scholar
  7. 7.
    Eron, L. J., Park, C. H., Hixon, H. L.: Ceftazidime in patients withPseudomonas infections. Journal of Antimicrobial Chemotherapy 1983, 12, Supplement A: 161–169.Google Scholar

Copyright information

© Vieweg Publishing 1985

Authors and Affiliations

  • B. E. de Pauw
    • 1
  • T. de Witte
    • 1
  • J. T. P. Janssen
    • 1
  • C. Haanen
    • 1
  1. 1.Division of HematologyUniversity Hospital, St. RadboudGA NijmegenThe Netherlands

Personalised recommendations